Sign in
4/A

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-18-046262

Options or other derivatives

  • Chief Scientific Officer acquired 4,137 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Biller Scott Chief Scientific Officer 2018-03-28 Option exercise · Stock option (right to buy) −37 1,766 D
Biller Scott Chief Scientific Officer 2018-03-28 Option exercise · Stock option (right to buy) −4,100 27,718 D
Loading xslF345X03/doc4a.xml…